Traders Recap: American Capital Agency Corp., Companhia de Bebidas das Americas, Pluristem Therapeutics Inc., Groupon Inc

Pompano Beach, FL -- (SBWIRE) -- 02/28/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-

American Capital Agency Corp. (NASDAQ:AGNC) shares dropped 3.54% to $31.61 in the early hour after the company today announced that it priced a public offering of 50 million shares of common stock for total expected gross proceeds of about $1.58 billion before expenses. In connection with the offering, the company has granted the underwriters an option for 30 days to purchase up to an additional 7.50 million shares of common stock. The offering is subject to customary closing conditions and is expected to close on March 5, 2013.

Can AGNC Continue To Move Higher? Find Out Here

Companhia de Bebidas das Americas (ADR) (NYSE:ABV) stock gained 0.96% to $44.29. The company, on Feb. 26, announced that, on February 25, 2013, its Board of Directors approved the distribution of dividend to be imputed to the obligatory minimum dividend for the 2012 fiscal year at the value of BRL 0.568 per ordinary share and BRL 0.6248 per preferred share. It also approved own capital interest to be imputed to the minimum obligatory dividend for the 2013 fiscal year at the value of BRL 0.08 per ordinary share (net value of BRL 0.068 per share) and BRL 0.088 per preferred share (net value of BRL 0.0748 per share).

How Should Investors Trade ABV Now? Find Out Here

Pluristem Therapeutics Inc. (NASDAQ:PSTI) stock jumped 0.60% to $3.36. The company announced that William R. Prather RPh, MD, its Senior VP of Corporate Development, will be presenting the Company at the Accredited Members Spring Small Cap/Micro Cap Conference, being held at the JW Marriott Resort and Spa on February 27th, 28th and March 1st.

Additionally, the company, last week, announced that the U.S. Food and Drug Administration (FDA) has designated Pluristem's PLacental eXpanded (PLX) cells orphan drug status for the treatment of aplastic anemia.

Can PSTI Extend Rally? Find Out Here

Groupon Inc (NASDAQ:GRPN) stock plunged 19.77% to $4.80 after the company yesterday reported a fourth quarter net loss of $0.12 per share which was flat with the prior year result. The consensus estimate was for a loss of $0.03. Revenues grew 30 percent to $638.3 million from $492.2 million last year. The consensus estimate was for revenues of $638.4 million.

Additionally, the company announced that Jason Child, Chief Financial Officer, will present at the Deutsche Bank dbAccess Media & Telecommunications Conference on Tuesday, March 5 at 2:05PM (EST) at The Breakers Hotel in Palm Beach, Florida.

How Should Investors React To GRPN Now? Find Out Here

About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
Csrnewsdaily.com
info@csrnewsdaily.com